BronchiolitisCareBESTNCT06506474
Low-value Care, and Variation in Practice for Children Hospitalized With Bronchiolitis
An observational study of Bronchiolitis, run by St. Justine's Hospital at 15 sites in Canada.
Trial summary
Low-value care is defined as the use of a health service, such as diagnostics and treatments, for which the harms or costs outweigh the benefits. In pediatrics, investigations or treatments can be unpleasant or traumatizing to the child, can prolong the time spent in hospital, and can create a cascade of further… Read more about this study
- Who is it for?
- Ages 28 days to 12 months
- Conditions the study is for
- Bronchiolitis
- What is being tested?
- Provision of any of six different low-value health services for treatment of bronchiolitis
- How many people
- 3,000 participants
- Where
- 15 sitesCanada
- Study dates
- 13 Feb 2024to Jun 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 28 days to 12 months
- All sexes
- Child
Study population: Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis.
Who may be able to join
- Children aged >28 days to <12 months
- Children admitted to a pediatric inpatient ward with an admission diagnosis of bronchiolitis
Who cannot join
- Children previously recruited for the study, either during a previous bronchiolitis admission or for the same incident of bronchiolitis, while admitted to another study site.
Trial locations and contacts
15 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Tamara Perez, MSc contact
15 sites in 1 country
Canada15 sites, 13 recruiting
- Recruiting
Alberta Children's Hospital
Calgary, Alberta, T3B 6A8
Michelle Bailey, MD, Michelle.Bailey@albertahealthservices.ca
Michelle Bailey, MD
- Not yet recruiting
Stollery Children's Hospital
Edmonton, Alberta, T6G 2B7
Karen Forbes, MD MEd, Karen.Forbes@albertahealthservices.ca
Karen Forbes, MD MEd
- Active, not recruiting
IWK Health
Halifax, Nova Scotia, B3K 6R8
- Recruiting
McMaster Children's Hospital
Hamilton, Ontario, L8N 3Z5
Gita Wahi, MD, wahig@mcmaster.ca
Fariha Chowdhury, chowdf1@mcmaster.ca
- Not yet recruiting
Kingston Health Science Centre
Kingston, Ontario, K7L 2V7
Anupam Sehgal, MD
Anupam Sehgal, MD
- Recruiting
Centre hospitalier Cité-de-la-Santé
Laval, Quebec, H7M 3L9
Camille Bédard-Gauthier, MD, camille.bedard-gauthier.med@ssss.gouv.qc.ca
Camille Bédard-Gauthier, MD
- Not yet recruiting
Children's Hospital of Western Ontario (London Health Science Centre)
London, Ontario, N6C 0B2
Breanna Chen, MD, BreannaAshley.Chen@lhsc.on.ca
Breanna Chen, MD
- Recruiting
Hôpital Maisonneuve-Rosemont
Montreal, Quebec, H1T 2M4
Marc-André Turcot, MD, marc-andre.turcot@umontreal.ca
Marc-André Turcot, MD
- Recruiting
CHU Sainte-Justine
Montreal, Quebec, H3T 1C5
Tamara Perez, MSc, tamara.perez.hsj@ssss.gouv.qc.ca
Isabelle Lahaie, MSc, isabelle.lahaie.hsj@ssss.gouv.qc.ca
- Not yet recruiting
Montreal Children's Hospital
Montreal, Quebec, H4A 3J1
Patricia Li, MD, MSc, patricia.li@mcgill.ca
Evelyn Constantin, MD, MSc, evelyn.constantin@mcgill.ca
- Recruiting
Lakeridge Health
Oshawa, Ontario, L1G 8A2
Mahmoud Sakran, MD, msakran@lh.ca
Mahmoud Sakran, MD
- Not yet recruiting
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1
Melanie Buba, mbuba@cheo.on.ca
Melanie Buba, MD
- Active, not recruiting
Centre Hospitalier Université Laval - Centre Mère-Enfant Soleil
Québec, Quebec, G1V 4G2
- Not yet recruiting
Hospital for Sick Children
Toronto, Ontario, M5G 1E8
Peter Gill, MD DPhil MSc
Shamama Raza, shamama.raza@sickkids.ca
- Recruiting
British Columbia Children's Hospital
Vancouver, British Columbia, V6H 3N1
Matthew Carwana, H.BSc, MD, Matthew.Carwana@cw.bc.ca
Candice Wiedman, Candice.Wiedman@bcchr.ca
About this study
Official title: Low-value Care, and Variation in Practice for Children Hospitalized With Bronchiolitis - a Multicentric Prospective Observational Study
Low-value care is defined as the use of a health service, such as diagnostics and treatments, for which the harms or costs outweigh the benefits. In pediatrics, investigations or treatments can be unpleasant or traumatizing to the child, can prolong the time spent in hospital, and can create a cascade of further futile investigations and treatments. Several of the commonly used diagnostics and treatments in bronchiolitis are considered low-value, making it a great model to study low-value care in pediatrics.
The purpose of CareBEST is to study the use of 6 low-value healthcare services in children aged 1 to 12 months hospitalized with bronchiolitis, their costs, and measure the variability in practice of these services.
Read more
The main questions this study aims to answer are:
- How frequently are 6 low-value care health services used in children hospitalized with bronchiolitis? These 6 low-value care health services are: 1) respiratory virus testing; 2) chest x-rays; 3) continuous pulse oximetry; 4) short-acting beta-agonists; 5) systemic corticosteroids; and 6) antibiotics.
- Are there factors that predict the use of these services?
- What are the costs of the use of these services?
- How much variability is there between different patients, different doctors, and between hospitals in the use of these 6 low-value health services ?
- Are differences in use of low-value health services associated with patient and family characteristics (like race and ethnicity, socioeconomic status, language), and do these contribute to disparities in care?
Participants will have their infant's medical chart reviewed during their hospitalization. They will also have 2 short questionnaires to complete, once during their child's admission to the hospital, and one 30 days later to ask about whether their child required any additional medical care. They will additionally be asked to complete a questionnaire on their perceptions regarding their child's care while hospitalized, including the use of shared-decision making and their understanding of and involvement in the care decisions made.
This analysis will provide a better understanding of treatment of bronchiolitis in Canada and help in the development of effective interventions to reduce low-value care.
Read the detailed description
Background: Low-value care is defined as the use of a health service, such as diagnostics and treatments, for which the harms or costs outweigh the benefits. Reducing low-value care is important in improving the health of Canadians and achieving a sustainable, high-quality healthcare system. Bronchiolitis is among the most common and most costly causes of hospitalizations in children. Most healthcare costs associated with bronchiolitis are related to hospitalization, and these costs have been increasing. Supportive care is recommended by national guidelines for the treatment of bronchiolitis, and many commonly used diagnostics and treatments in bronchiolitis are considered low-value, making it a great model to study low-value care in pediatrics. To develop effective interventions to reduce low-value care, and ensure the right resources go to the right patient at the right time, it is crucial to develop a better understanding of inpatient management of bronchiolitis in Canada.
The goal of this prospective multi-site observational study is to analyze the use of 6 low-value healthcare services in children diagnosed with bronchiolitis, their costs, and measure the variability in practice of these services.
Specific objectives: Among infants admitted with bronchiolitis at 15 Canadian hospitals with pediatric admissions, to:
- Measure the incidence, patterns, and predictors of use of 6 low-value care health services and their costs in children hospitalized for bronchiolitis, namely 1) respiratory virus testing; 2) chest x-rays; 3) continuous pulse oximetry; 4) short-acting beta-agonists; 5) systemic corticosteroids; and 6) antibiotics;
- Estimate the extent of practice variation in the use of 6 low-value health services between hospitals;
- Determine whether differences in use of low-value health services are associated with patient and family characteristics (e.g., race and ethnicity, socioeconomic status, language), and whether these contribute to disparities in care.
Design: A multi-centre (n=15), prospective observational cohort study of children hospitalized with bronchiolitis. Data will be obtained from medical charts and entered into a central, web-based REDCap database. A health equity questionnaire will be completed by participants once during their child's admission and then again 30 days later to inquire on additional medical care required post-admission. Secondary outcomes and covariates will also be collected which include but are not limited to duration of ICU stay, use of mechanical ventilation, cardiac arrest, length of hospital stay, disease severity, clinician years of experience, and death.
Analysis of the primary outcome will be descriptive for each low-value health service, overall and stratified by sex. Costs of hospitalization will be assessed from a healthcare institution perspective. Cost of each of low-value health service will be described and compared between one another and across sites to identify key differences which may be targets for process change.
This study will provide important data to understand the use of low-value care in bronchiolitis treatment in Canada, and will inform our approach to addressing low-value care in bronchiolitis and in other common conditions.
- Conditions
- Bronchiolitis
- Being tested
- Provision of any of six different low-value health services for treatment of bronchiolitis
- Keywords
- infants, hospitalization, bronchiolitis, low-value care, observational study
- Medical subject headings
- Bronchiolitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Provision of any of six different low-value health services for treatment of bronchiolitisDiagnostic test
This prospective observational will have six separate primary outcomes acting as exposures, (or interventions).The exposures are the the provision of any of the six low-value health services: 1) respiratory virus testing; 2) chest x-ray; 3) continuous pulse oximetry; 4) short-acting beta-agonists; 5) systemic corticosteroids; and 6) antibiotics.
| Study group | Role | What they receive |
|---|---|---|
| Children admitted to CHU Sainte-Justine | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis | |
| Children admitted to McMaster Children's Hospital | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis | |
| Children admitted to British Columbia Children's Hospital | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis | |
| Children admitted to IWK Children's Hospital | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis | |
| Children admitted to CHU de Quebec University Laval Hospital | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis | |
| Children admitted to Montreal Children's Hospital | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis | |
| Children admitted to Children's Hospital of Eastern Ontario | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis | |
| Children admitted to Kingston Health Sciences Centre | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis | |
| Children admitted to The Hospital for Sick Children | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. | |
| Children admitted to Children's Hospital of Western Ontario | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis | |
| Children admitted to Alberta Children's Hospital | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis | |
| Children admitted to Stollery Children's Hospital | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis | |
| Children Admitted to Hôpital Maisonneuve-Rosemont | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis | |
| Children admitted to Cité-de-la-Santé | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis | |
| Children admitted to Lakeridge Health | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. Receives: Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitis |
What is being measured
The primary outcome is the main question the study is designed to answer.
The proportion of eligible patients receiving each of the six low-value health services
The primary outcome of the study is the proportion of patients receiving each of the six low-value health services during their hospitalization for bronchiolitis: 1) respiratory virus testing; 2) chest x-ray; 3) continuous pulse oximetry; 4) short-acting beta-agonists; 5) systemic corticosteroids; and 6) antibiotics.
Measured: 24 months
Secondary outcomes (21)
Transfer to the ICU
Whether the child admitted with bronchiolitis was transferred to the ICU. If so, duration of ICU stay.
Measured: 24 months
Use of CPAP, BiPAP, or mechanical ventilation during admission.
Use of continuous positive airway pressure (CPAP) or biphasic positive airway pressure (BiPAP), mechanical ventilation during admission, as documented in patient's admission record.
Measured: 24 months
Cardiac arrest
Whether the child experienced a cardiac arrest during their admission.
Measured: 24 months
Death
Whether the child died during their admission.
Measured: 24 months
Return visits
Using administrative data and parent surveys, we will measure return visits to the Emergency Department, and hospitalizations within 30 days following the initial bronchiolitis admission, overall and for respiratory illness.
Measured: 24 months
Use of low-flow supplemental oxygen
Any use of low-flow supplemental oxygen, and duration of use.
Measured: 24 months
Fluid supplementation
Presence and type (intravenous vs. nasogastric) of fluid supplementation
Measured: 24 months
Nil per os order
Any order for "nil per os" (feeding not permitted) during admission.
Measured: 24 months
Chest X-ray results
Results of chest X-rays ordered. Obtained from medical record.
Measured: 24 months
Presence of bacterial co-infection
Presence and type of bacterial co-infections. Obtained from medical record.
Measured: 24 months
Use of inhaled corticosteroids
Whether inhaled corticosteroids were administered during admission. Obtained from medical record.
Measured: 24 months
Use of chest physiotherapy
Whether chest physiotherapy was performed during admission. Obtained from medical record.
Measured: 24 months
Complete blood count
Results of complete blood count. Obtained from medical record. Numerical
Measured: 24 months
Electrolyte levels
Electrolyte levels in blood. Obtained from medical record. Numerical
Measured: 24 months
Venous blood gas
Results of blood tests ordered; venous blood gas. Obtained from medical record. Numerical
Measured: 24 months
Antiviral prescription
Any prescription for an antiviral effective against influenza during admission.Obtained from medical record.
Measured: 24 months
Prescription at discharge from hospital
Data collection on prescription at discharge from the hospital including the following: 1) repeat chest x-ray; 2) prescription for short-acting beta-agonists (SABA); 3) inhaled corticosteroids; 4) systemic corticosteroids; 5) antibiotics; and 6) antivirals.
Measured: 24 months
Care received in the 30 days following discharge.
Care received in the 30 days following the patient's discharge from the hospital, including outpatient follow-up appointments in the following 30 days, follow-up chest x-rays, as well as prescription for antibiotics, short-acting beta-agonists, and inhaled corticosteroids.
Measured: 24 months
Length of stay
Length of hospital stay in hours, both in the ED and inpatient unit, measured using recorded time of arrival and departure to and from the ED and inpatient unit.
Measured: 24 months
Cost of hospitalization
Cost of hospitalization will be evaluated from a healthcare institution perspective with data from hospital decision support. More detailed costs data (micro-costing) will also be obtained whenever possible, allowing differentiation between services not readily discerned by traditional case costing methods typically based on resource intensity weights.
Measured: 24 months
Use of Heated humidified high-flow nasal cannula (HHHFNC)
Heated humidified high-flow nasal cannula (HHHFNC) help reduce work of breathing and can be beneficial in severe bronchiolitis cases. We will measure proportion of HHHFNC use in hospitalized children with bronchiolitis stratified by disease severity. Obtained from medical record.
Measured: 24 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2024
- Study start13 Feb 2024
- Primary completionMay 2026 (estimated)
- Study completionJun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for BronchiolitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 3,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- St. Justine's Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Children's Hospital of Eastern Ontario, Maternal Infant Child and Youth Research Network, The Hospital for Sick Children, Unity Health Toronto
- Responsible party
- Principal investigator, Olivier Drouin, M.D., M.Sc M.P.H., St. Justine's Hospital
- Investigators
- Olivier Drouin, MD, MSc, MPH, Principal investigator, CHU Sainte-Justine Research Centre
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06506474
- Sponsor's protocol ID
- 2024-5815
- Acronym
- CareBEST
- Status last verified
- Jul 2025
- First submitted
- 30 May 2024
- Last updated
- 23 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Low-value Care, and Variation in Practice for Children Hospitalized With Bronchiolitis - a Multicentric Prospective Observational Study
- ClinicalTrials.gov ID
- NCT06506474
- Acronym / sponsor ID
- CareBEST / 2024-5815
- Conditions
- Bronchiolitis
- Keywords
- infants, hospitalization, bronchiolitis, low-value care, observational study
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 3,000 participants (estimated)
- Lead sponsor
- St. Justine's HospitalUniversity, hospital or other
- Collaborators
- Children's Hospital of Eastern Ontario, Maternal Infant Child and Youth Research Network, The Hospital for Sick Children, Unity Health Toronto
- Study start
- 13 Feb 2024 (actual)
- Primary completion
- May 2026 (estimated)
- Study completion
- Jun 2027 (estimated)
- First posted
- 17 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Low-value care is defined as the use of a health service, such as diagnostics and treatments, for which the harms or costs outweigh the benefits. In pediatrics, investigations or treatments can be unpleasant or traumatizing to the child, can prolong the time spent in hospital, and can create a cascade of further futile investigations and treatments. Several of the commonly used diagnostics and treatments in bronchiolitis are considered low-value, making it a great model to study low-value care in pediatrics.
The purpose of CareBEST is to study the use of 6 low-value healthcare services in children aged 1 to 12 months hospitalized with bronchiolitis, their costs, and measure the variability in practice of these services.
The main questions this study aims to answer are:
- How frequently are 6 low-value care health services used in children hospitalized with bronchiolitis? These 6 low-value care health services are: 1) respiratory virus testing; 2) chest x-rays; 3) continuous pulse oximetry; 4) short-acting beta-agonists; 5) systemic corticosteroids; and 6) antibiotics.
- Are there factors that predict the use of these services?
- What are the costs of the use of these services?
- How much variability is there between different patients, different doctors, and between hospitals in the use of these 6 low-value health services ?
- Are differences in use of low-value health services associated with patient and family characteristics (like race and ethnicity, socioeconomic status, language), and do these contribute to disparities in care?
Participants will have their infant's medical chart reviewed during their hospitalization. They will also have 2 short questionnaires to complete, once during their child's admission to the hospital, and one 30 days later to ask about whether their child required any additional medical care. They will additionally be asked to complete a questionnaire on their perceptions regarding their child's care while hospitalized, including the use of shared-decision making and their understanding of and involvement in the care decisions made.
This analysis will provide a better understanding of treatment of bronchiolitis in Canada and help in the development of effective interventions to reduce low-value care.
Detailed description
Background: Low-value care is defined as the use of a health service, such as diagnostics and treatments, for which the harms or costs outweigh the benefits. Reducing low-value care is important in improving the health of Canadians and achieving a sustainable, high-quality healthcare system. Bronchiolitis is among the most common and most costly causes of hospitalizations in children. Most healthcare costs associated with bronchiolitis are related to hospitalization, and these costs have been increasing. Supportive care is recommended by national guidelines for the treatment of bronchiolitis, and many commonly used diagnostics and treatments in bronchiolitis are considered low-value, making it a great model to study low-value care in pediatrics. To develop effective interventions to reduce low-value care, and ensure the right resources go to the right patient at the right time, it is crucial to develop a better understanding of inpatient management of bronchiolitis in Canada.
The goal of this prospective multi-site observational study is to analyze the use of 6 low-value healthcare services in children diagnosed with bronchiolitis, their costs, and measure the variability in practice of these services.
Specific objectives: Among infants admitted with bronchiolitis at 15 Canadian hospitals with pediatric admissions, to:
- Measure the incidence, patterns, and predictors of use of 6 low-value care health services and their costs in children hospitalized for bronchiolitis, namely 1) respiratory virus testing; 2) chest x-rays; 3) continuous pulse oximetry; 4) short-acting beta-agonists; 5) systemic corticosteroids; and 6) antibiotics;
- Estimate the extent of practice variation in the use of 6 low-value health services between hospitals;
- Determine whether differences in use of low-value health services are associated with patient and family characteristics (e.g., race and ethnicity, socioeconomic status, language), and whether these contribute to disparities in care.
Design: A multi-centre (n=15), prospective observational cohort study of children hospitalized with bronchiolitis. Data will be obtained from medical charts and entered into a central, web-based REDCap database. A health equity questionnaire will be completed by participants once during their child's admission and then again 30 days later to inquire on additional medical care required post-admission. Secondary outcomes and covariates will also be collected which include but are not limited to duration of ICU stay, use of mechanical ventilation, cardiac arrest, length of hospital stay, disease severity, clinician years of experience, and death.
Analysis of the primary outcome will be descriptive for each low-value health service, overall and stratified by sex. Costs of hospitalization will be assessed from a healthcare institution perspective. Cost of each of low-value health service will be described and compared between one another and across sites to identify key differences which may be targets for process change.
This study will provide important data to understand the use of low-value care in bronchiolitis treatment in Canada, and will inform our approach to addressing low-value care in bronchiolitis and in other common conditions.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 15
| Arm | Type | Receives |
|---|---|---|
| Children admitted to CHU Sainte-Justine | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to McMaster Children's Hospital | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to British Columbia Children's Hospital | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to IWK Children's Hospital | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to CHU de Quebec University Laval Hospital | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to Montreal Children's Hospital | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to Children's Hospital of Eastern Ontario | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to Kingston Health Sciences Centre | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to The Hospital for Sick Children | – | –Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to Children's Hospital of Western Ontario | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to Alberta Children's Hospital | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to Stollery Children's Hospital | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children Admitted to Hôpital Maisonneuve-Rosemont | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to Cité-de-la-Santé | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to Lakeridge Health | – | Diagnostic Test: Provision of any of six different low-value health services for treatment of bronchiolitisChildren aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
Who may qualify
- Ages
- 28 days to 12 months
- Sex
- All
- Age groups
- Child
- Study population
- Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis.
Key inclusion criteria (2 listed)
- Children aged >28 days to <12 months
- Children admitted to a pediatric inpatient ward with an admission diagnosis of bronchiolitis
Key exclusion criteria (1 listed)
- Children previously recruited for the study, either during a previous bronchiolitis admission or for the same incident of bronchiolitis, while admitted to another study site.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Provision of any of six different low-value health services for treatment of bronchiolitisThis prospective observational will have six separate primary outcomes acting as exposures, (or interventions).The exposures are the the provision of any of the six low-value health services: 1) respiratory virus testing; 2) chest x-ray; 3) continuous pulse oximetry; 4) short-acting beta-agonists; 5) systemic corticosteroids; and 6) antibiotics. | Diagnostic test | Children Admitted to Hôpital Maisonneuve-Rosemont, Children admitted to Alberta Children's Hospital, Children admitted to British Columbia Children's Hospital, Children admitted to CHU Sainte-Justine, Children admitted to CHU de Quebec University Laval Hospital, Children admitted to Children's Hospital of Eastern Ontario, Children admitted to Children's Hospital of Western Ontario, Children admitted to Cité-de-la-Santé, Children admitted to IWK Children's Hospital, Children admitted to Kingston Health Sciences Centre, Children admitted to Lakeridge Health, Children admitted to McMaster Children's Hospital, Children admitted to Montreal Children's Hospital, Children admitted to Stollery Children's Hospital |
Primary outcome
The proportion of eligible patients receiving each of the six low-value health services
Time frame: 24 months
The primary outcome of the study is the proportion of patients receiving each of the six low-value health services during their hospitalization for bronchiolitis: 1) respiratory virus testing; 2) chest x-ray; 3) continuous pulse oximetry; 4) short-acting beta-agonists; 5) systemic corticosteroids; and 6) antibiotics.
21 secondary outcomes
Transfer to the ICU
Time frame: 24 months
Use of CPAP, BiPAP, or mechanical ventilation during admission.
Time frame: 24 months
Cardiac arrest
Time frame: 24 months
Death
Time frame: 24 months
Return visits
Time frame: 24 months
Use of low-flow supplemental oxygen
Time frame: 24 months
Fluid supplementation
Time frame: 24 months
Nil per os order
Time frame: 24 months
Chest X-ray results
Time frame: 24 months
Presence of bacterial co-infection
Time frame: 24 months
Use of inhaled corticosteroids
Time frame: 24 months
Use of chest physiotherapy
Time frame: 24 months
Complete blood count
Time frame: 24 months
Electrolyte levels
Time frame: 24 months
Venous blood gas
Time frame: 24 months
Antiviral prescription
Time frame: 24 months
Prescription at discharge from hospital
Time frame: 24 months
Care received in the 30 days following discharge.
Time frame: 24 months
Length of stay
Time frame: 24 months
Cost of hospitalization
Time frame: 24 months
Use of Heated humidified high-flow nasal cannula (HHHFNC)
Time frame: 24 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Bronchiolitis
Active, not recruiting
Respiratory Support and Treatment for Efficient and Cost-Effective Care
Bronchiolitis
RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Belumosudil Compared With Best Available Therapy in Participants Aged 12 Years or Older With Chronic Graft-versus-host Disease
Chronic Graft Versus Host Disease
Not yet recruiting
Influence of Patient Positioning During Nasal Lavage
Acute Upper Respiratory Tract Infections, Nasal Obstruction
Recruiting
Effect of Anomia Rehabilitation Combined With Metacognitive Training in Patients With Chronic Vascular Aphasia
Aphasia, Stroke
Not yet recruiting
A New ECP Protocol for the Treatment of cGVHD
Chronic Graft Versus Host Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Tamara Perez, MSc contact
Olivier Drouin, MD, MSc, MPH principal investigator
CHU Sainte-Justine Research Centre
15 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Bronchiolitis, run by St. Justine's Hospital at 15 sites in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 23 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 15 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Olivier Drouin, MD, MSc, MPH (514 345-4931 ext. 4226, olivier.drouin.hsj@ssss.gouv.qc.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The proportion of eligible patients receiving each of the six low-value health services (time frame: 24 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2025.